Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose mirtazapine and quetiapine for experimentally induced insomnia
NL-OMON40193Phase 4Not yet recruiting
- Sponsor
- GGZ Drenthe
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Insomnia comparing Mirtazapine sequence, Quetiapine sequence and Placebo sequence (3 arms). Primary endpoints: Sleep polysomnography and Subjective sleep. Planned start Aug 2014; status: not yet recruiting.
02
Drugs
mirtazapinequetiapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON40193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40193.